Navigation Links
Instant Plus

ProductsInstant Plus
Company Roche Diagnostics
Item Instant Plus
Features 
  • A single, economical monitor that tests both cholesterol and glucose saves you money.
  • Reliable reflectance technology provides consistent results.
  • The hand-held Accu-Chek InstantPlus Meter is lightweight, so it is easy to test anywhere.
  • Choice of cholesterol or glucose test strip automatically indicates choice of test.
  • Three AAA batteries supply enough power for over 1000 tests.
Description The Accu-Chek InstantPlus Meter is Roche Diagnostics' only compact meter that can perform cholesterol and glucose with the same system. This simple, CLIA-waived test provides total cholesterol results in only 180 seconds. So you can develop effective therapy programs during a patients office consultation.
Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. Instant-View LH Ovulation Predicting Test
2. 3M Avagard D Instant Hand Antiseptic with Moisturizers
3. Herbal Fragrance Gel Instant Hand Sanitizer
Poly stat Strep A is a lateral flow, one-step immunoassay for the rapid, qualitative detection of Group A Streptococcal antigen from throat swabs. The test is intended for use as an aid in the diagn
...he ProTime Microcoagulation System monitors warfar...ient self-testing. Enhancements include an easy-t...le and replaceable battery. Software updates incl... computer or be transmitted to a LIS or EMR databa...
...ince 1994 the CoaguChek System has been providing ...eeded most, at the point of care. , The CoaguChe... of patients self-testing when monitoring on Couma...m allows the user to obtain a result from a finger...
...he Instacup Multi-Drug Screen Panel is used for th...man urine. The Instacup Panel consists of a test c... test card is inserted and the sample sealed with ...ot necessary to remove the test card to read the r...
Medicine Products:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...he spread of the disease are clearly not working a...// on a global basis if the disease is to be conta...ups of sex workers and drug addicts. It is here t...ortance. Individuals the world over, both in devel...
...ted by Welcare World Health Systems, has been lau...bulatory health care service comprising of outpati.../ services had been recently inagurated in Knowle... Ambulatory Care Center is open from 8 am to 11 pm...
...cross the world, according to the Center for Socia...bin Room. About 4.4% of deaths are accounted for b.... Alcohol is also responsible for as many deaths a...aws have reportedly failed to take note of this fa...
...al and Experimental Research which has revealed th... result in lesser consumption//. It only contribut...ior liquor. Researchers believe across-the-board ...e intended effects on alcohol sales, and suggest '...
Other Medicine News:Health News:Need of the Hour: Viable Strategies against AIDS 2Health News:State Of The Art Healthcare Facility Opened In 'New Dubai' by Welcare 2Health News:Price Of Alcohol Does Not Influence Consumption 2
(Date:10/7/2008)...INS, Colo., Oct. 7 /- A study publish...yonic stem cell self-renewal,reported that InVitr...inant,human serum albumin) was an effective replac... The article entitled, "The ground state of embry...rchers used Cellastim as a recombinant,albumin in ...
(Date:10/7/2008)..., Mass., Oct. 7 /- Taligen Therapeuti...al of the Company,s pipeline,candidates were prese... in,Basel, Switzerland. The data highlighted the c...mplement-mediated diseases., "These highlighted p...presented at the conference, reveal the deep exper...
(Date:10/7/2008)...bstracts highlighting CIMZIA,s long-term benefits ...tients presented at American College,of Gastroente...rstCall/ -- Data from two studies,presented this w...logy,(ACG) Annual Meeting demonstrate that CIMZIA(...TNF alpha (Tumor Necrosis Factor alpha) - provides...
(Date:10/7/2008)..., Oct. 7 /- Ardea Bioscienc...oster entitled "RDEA119, a Potent,and Highly Selec...fate,Sodium (DSS) -- induced Chronic Colitis in Mi...roenterology (ACG) 2008 Annual Meeting in Orlando,...reclinical study of,RDEA119, the Company,s lead mi...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Studies Reveal Why Breast Cancer Hits Black Women Harder 7238 1Studies Reveal Why Breast Cancer Hits Black Women Harder 7238 2Studies Reveal Why Breast Cancer Hits Black Women Harder 7238 3Stroke study to add patients who cannot give immediate consent 7234 1Stroke study to add patients who cannot give immediate consent 7234 2Stroke study to add patients who cannot give immediate consent 7234 3Irene Hegeman Richard MD Appointed Senior Medical Advisor to The Michael J Fox Foundation 7230 1Irene Hegeman Richard MD Appointed Senior Medical Advisor to The Michael J Fox Foundation 7230 2Malaria Community Applauds Clintons 241 Billion a Year Pledge 3B Invites Other Candidates to Make Malaria Commitments 7226 1Malaria Community Applauds Clintons 241 Billion a Year Pledge 3B Invites Other Candidates to Make Malaria Commitments 7226 2Malaria Community Applauds Clintons 241 Billion a Year Pledge 3B Invites Other Candidates to Make Malaria Commitments 7226 3
...rQule, Inc.,(NASDAQ: ARQL) today announced that th... accepted for oral presentation the,Company,s abst...of,ARQ 197, a Selective Inhibitor of the c-Met Rec... the 43rd ASCO Annual Meeting, June,1-5, 2007, in ...from a Phase 1 trial with ARQ 197, a selective, sm...
...II Trial Results,For Novel Oral Thrombin Receptor ...can College Of Cardiology/i2 Summit, KENILWORTH, N...ring-Plough Corporation announced today that resul...n receptor antagonist (TRA),SCH 530348 will be pre...he of Cardiology (ACC.07)/Innovation in Interventi...
Other Medicine Technology:ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 2ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 4Media Advisory: ACC Updated Schedule 2